Patidar, A and Selvaraj , S and Chakravarti, M and Guha, I and Bhuniya, A and Bera , S and Dhar , S and Roy, K and Baral, R and Chattopadhyay, D and Pal , C and Saha , B (2022) TLR induced IL-27 plays host-protective role against B16BL6 melanoma in C57BL/6 mice. Cytokine, 154. p. 155871.

Full text not available from this repository. (Request a copy)

Abstract

Elicitation of the tumor-eliminating immune response is a major challenge, as macrophages- constituting a major component of solid tumor mass- play important roles in development, maintenance and tumor regression. The macrophage-expressed Toll-Like Receptors (TLRs) enhance macrophage function and their ability to activate T cells via secretion of cytokines, which may help in tumor regression. IL-27, a member of the IL-12 family of cytokines, is shown to exhibit anti-tumor and anti-angiogenic activities. Herein, we developed B16BL6 melanoma model in C75BL/6 mouse to dissect the crosstalk between TLRs and IL-27 in tumors. We report existence of a novel TLR- IL-27 feed-forward loop, whereby TLRs and IL-27 up-regulated each other's expression, which we found perturbed during melanoma tumorigenesis. Intra-tumoral injection of Imiquimod, a TLR7/8 ligand, reduced the tumor burden; the anti-tumor effect was reversed upon IL-27 and IL-27R silencing by intra-tumorally administered, lentivirally expressed IL-27 and IL-27R shRNA. The reduced tumor growth was accompanied by significantly fewer Treg cells but increased IFN-γ and granzyme B expression by CD8+ T cells. These data indicate the preventative role for TLR-induced IL-27 in aggressive and highly invasive melanoma.

Item Type:	Article
Subjects:	Infection and Immunity
Depositing User:	Mr. Rameshwar Nema
Date Deposited:	19 Oct 2022 07:27
Last Modified:	19 Oct 2022 07:27
URI:	http://nccs.sciencecentral.in/id/eprint/1178

Actions (login required)

View Item